We seek to back exceptional management teams in structurally attractive healthcare sectors that have sizeable market potential, excellent growth prospects, attractive innovation opportunities and manageable pricing trends and competition.
Drawing on our real-world experience as healthcare business developers, operators, marketers and investors, Hildred is helping to transform a diverse portfolio of today’s successful middle-market enterprises into tomorrow’s category leaders.
Practice management, telemedicine, virtual care, home care, ambulatory care, and pharmacy are just a few of service trends transforming today’s healthcare system.
is a dermatology practice management platform. DermCare is a leading national platform with 55+ clinics across three states.
Consumer products serve as the first line of healthcare defense for millions of Americans and can deliver significant value to the healthcare system. The growth prospects for this industry are excellent.
is a marketer and manufacturer of natural and homeopathic consumer healthcare products with a long history of being a preferred brand in the health & wellness category. Sells its diverse products into top retailers and direct to consumers across several high growth categories.
COVID-19 accelerated the digital transformation of healthcare. This sector holds great promise and has the potential to improve healthcare access and affordability worldwide.
is a data-driven platform offering personalized insurance plans and products directly to consumers.
Demand for innovative services related to the pharmaceutical supply chain, distribution, clinical trials, medication dispensing and data collection are at an all time high.
is a science-driven CDMO focused on sterile technologies and complex-to-formulate oral solid pharmaceuticals. Offers scientific insights and depth of product knowledge, providing a full range of parenteral and oral dosage forms at every stage of clinical development and commercialization.
Innovative medical devices are being used to more effectively identify, diagnose, treat and monitor disease. Point-of-care diagnostics, imaging solutions, wearables, among other innovations are changing healthcare.
is novel PCR-based point of care diagnostics platform for STI (sexually transmitted infections) and COVID. Markets and develops innovative technologies that address testing market inefficiencies.
First choice for healthcare businesses who seek first-time institutional capital and a true partner.
Comprehensive services and expertise helps successful companies become category leaders.
Delivers heavyweight up-market level of expertise and resources to the middle market in U.S.and Canada.
Drives outsized returns and tangible outcomes through precise, tried-and-true execution.
“Over the course of our partnership, Hildred has provided Hyland’s with hands-on operational expertise, smart strategic guidance, and real assistance. The Hildred team possesses a true operator’s mindset, allowing us to make the best decisions for our business that create long-term, lasting value.”
Certain statements about Hildred made by portfolio company executives herein are intended to illustrate Hildred’s business relationship with such persons, including with respect to Hildred’s facilities as a business partner, rather than Hildred’s capabilities or expertise with respect to investment advisory services. Portfolio company executives were not compensated in connection with their participation, although they generally receive compensation and investment opportunities in connection with their portfolio company roles, and in certain cases are also owners of portfolio company securities and/or investors in Hildred-sponsored vehicles. Such compensation and investments subject participants to potential conflicts of interest in making the statements herein.